Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTSH vs GSK✓SelectedUSD · GSKCTSH vs GSK performance historyLatest closeAs of-1.14%11/16
Stock and ETF performance explorer

CTSH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+27.5%
GSK return
+108.8%
Excess return
-81.3%
Maximum drawdown
-56.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-1.1%-1.1%
7D-1.6%-1.3%-0.2%-1.0%
30D-5.2%+2.7%-7.9%-6.2%
3M+7.1%+2.7%+4.4%+5.9%
6M+34.6%+3.3%+31.2%+32.5%
YTD-23.2%+6.5%-29.7%-26.0%
1Y-11.8%+10.7%-22.5%-16.4%
3Y-3.5%+64.4%-67.8%-25.2%
5Y-16.6%+46.7%-63.3%-33.1%
All+27.5%+108.8%-81.3%-12.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling